Statin for Tuberculosis and Pneumonia in Patients with Asthma?Chronic Pulmonary Disease Overlap Syndrome: A Time-Dependent Population-Based Cohort Study.

ABSTRACT: We investigated the effects of statins on tuberculosis (TB) and pneumonia risks in asthma?chronic pulmonary disease overlap syndrome (ACOS) patients. We extracted data of patients diagnosed as having ACOS during 2000?2010 from the Taiwan National Health Insurance Research Database and divided them into statin users and nonusers. All study participants were followed up from the index date until death, withdrawal from insurance, or TB and pneumonia occurred (31 December 2011). The cumulative TB and pneumonia incidence was analyzed using Cox proportional regression analysis with time-dependent variables. After adjustments for multiple confounding factors including age, sex, comorbidities, and use of medications [statins, inhaled corticosteroids (ICSs), or oral steroids (OSs)], statin use was associated with significantly lower TB [adjusted hazard ratio (aHR) 0.49, 95% confidence interval (CI) 0.34?0.70] and pneumonia (aHR 0.52, 95% CI 0.41?0.65) risks. Moreover, aHRs (95% CIs) for statins combined with ICSs and OSs were respectively 0.60 (0.31?1.16) and 0.58 (0.40?0.85) for TB and 0.61 (0.39?0.95) and 0.57 (0.45?0.74) for pneumonia. Thus, statin users had lower TB and pneumonia risks than did nonusers, regardless of age, sex, comorbidities, and ICS or OS use. Pneumonia risk was lower among users of statins combined with ICSs or Oss and TB risk was lower among the users of statins combined with OSs.

SUBMITTER: Yeh JJ 

PROVIDER: S-EPMC6262333 | biostudies-other | 2018 Oct

REPOSITORIES: biostudies-other